Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Avutometinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031747822/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009704485/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer

    29 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240729473398/en

    BUSINESSWIRE
    29 Jul 2024
    Share Share
    ASCO: Verastem’s combo therapy for pancreatic cancer hits early trial success
    ASCO: Verastem’s combo therapy for pancreatic cancer hits early trial success

    25 May 2024

    // Robert Barrie CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/asco-2024-verastems-combo-therapy-for-pancreatic-cancer-hits-early-trial-success/#:~:text=clinical%20research%20companies-,ASCO%202024%3A%20Verastem\'s%20combo%20therapy%20for%20pancreatic%20cancer%20hits%20early,%25%20in%20pre%2Dmarket%20trading.&text=Verastem%20will%20present%20the%20results,Meeting%20on%201%20June%202024.

    Robert Barrie CLINICALTRIALSARENA
    25 May 2024
    Share Share
    Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone
    Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305616374/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    Verastem Oncology Outlines Key 2024 Strategic Priorities
    Verastem Oncology Outlines Key 2024 Strategic Priorities

    29 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240124822477/en

    BUSINESSWIRE
    29 Jan 2024
    Share Share